ABBVIE INC.

ABBV · NEW YORK STOCK EXCHANGE INC.

Pharmaceutical Preparation Manufacturing · US

AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. The Company strives to have a remarkable impact on people's lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women's health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio.

ESG Overview

Overall: BBB (High)

E: AS: BBG: BB

ESG grades from public dataset.

ESG data: Public Company ESG Ratings (CC BY-NC-SA 4.0)

Market Data

Price $227.34 -0.11 (-0.05%)

Market Cap$398.70B

P/E Ratio94.35

EPS$—

52W High$244.81

52W Low$164.39

Beta0.33

Data from Finnhub · Updated Mar 10, 2026